Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.22.1 (
DNase II
)
429
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The differentiation of rat liver lysosomal acid phosphatase, acid ATPase, acid phosphodiesterase, acid ribonuclease, and
acid deoxyribonuclease
was studied by isoelectric focusing. To prevent autolytic digestion, inhibitors of cathepsins and
neuraminidase
were used. The proportion of acidic forms of acid phosphatase, acid ATPase and acid phosphodiesterase was increased by the use of extraction medium containing 0.05% Triton X-100. To investigate the identity of acid ATPase and acid phosphodiesterase, the relative activities among the multiple forms of these enzymes, the acid phosphodiesterase/acid ATPase ratio at each activity peak, and the degree of enzyme inhibition by p-chloromercuriphenyl sulfonic acid were estimated. The results suggest that acid ATPase is not identical with acid phosphodiesterase. With extraction medium free of Triton X-100, acid ribonuclease appeared in two forms. However, in addition to these forms, a new form of this enzyme with a more acidic pI (4.22) emerged when extraction medium containing 0.05% Triton X-100 was used. The major peak of
acid deoxyribonuclease
with pI=8.40-9.39 was obtained regardless of the extracting method.
...
PMID:An isoelectric focusing study of acid phosphohydrolases in rat liver lysosomes. 2 87
Homogenates of HeLa cells contain
neuraminidase
activity. This enzyme is particle-bound, and it has a pH optimum of 4.2. Hydrocortisone-regulated cells contain two to three times as much
neuraminidase
as the corresponding controls. The hydrocortisone treatment also causes an increase in the cell content of beta-glucuronidase and
acid deoxyribonuclease
.
...
PMID:Neuraminidase activity in hela cells: effect of hydrocortisone. 547 38